Journal article
Exploring the relationship between polygenic risk for cannabis use, peer cannabis use and the longitudinal course of cannabis involvement
Addiction (Abingdon, England), Vol.114(4), pp.687-697
04/2019
DOI: 10.1111/add.14512
PMCID: PMC6411425
PMID: 30474892
Abstract
Few studies have explored how polygenic propensity to cannabis use unfolds across development, and no studies have yet examined this question in the context of environmental contributions such as peer cannabis use. Outlining the factors that contribute to progression from cannabis initiation to problem use over time may ultimately provide insights into mechanisms for targeted interventions. We sought to examine the relationships between polygenic liability for cannabis use, cannabis use trajectories from ages 12-30 years and perceived peer cannabis use at ages 12-17 years.
Mixed-effect logistic and linear regressions were used to examine associations between polygenic risk scores, cannabis use trajectory membership and perceived peer cannabis use.
United States.
From the Collaborative Study on the Genetics of Alcoholism (COGA) study, a cohort of 1167 individuals aged 12-26 years at their baseline (i.e. first) interview.
Key measurements included life-time cannabis use (yes/no), frequency of past 12-month cannabis use, maximum life-time frequency of cannabis use, cannabis use disorder (using DSM-5 criteria) and perceived peer cannabis use. Polygenic risk scores (PRS) were created using summary statistics from a large (n = 162 082) genome-wide association study (GWAS) of cannabis use.
Three trajectories reflecting no/low (n = 844), moderate (n = 137) and high (n = 186) use were identified. PRS were significantly associated with trajectory membership [P = 0.002-0.006, maximum conditional R
= 1.4%, odds ratios (ORs) = 1.40-1.49]. Individuals who reported that most/all of their best friends used cannabis had significantly higher PRS than those who reported that none of their friends were users [OR = 1.35, 95% confidence interval (CI) = 1.04, 1.75, P = 0.023]. Perceived peer use itself explained up to 11.3% of the variance in trajectory class membership (OR = 1.50-4.65). When peer cannabis use and the cannabis use PRS were entered into the model simultaneously, both the PRS and peer use continued to be significantly associated with class membership (P < 0.01).
Genetic propensity to cannabis use derived from heterogeneous samples appears to correlate with longitudinal increases in cannabis use frequency in young adults.
Details
- Title: Subtitle
- Exploring the relationship between polygenic risk for cannabis use, peer cannabis use and the longitudinal course of cannabis involvement
- Creators
- Emma C Johnson - Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USARebecca Tillman - Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USAFazil Aliev - Department of Actuarial and Risk Management, Faculty of Business, Karabuk University, TurkeyJacquelyn L Meyers - Department of Psychiatry, SUNY Downstate Medical Center, Brooklyn, NY, USAJessica E Salvatore - Department of Psychology, Virginia Commonwealth University, Richmond, VA, USAAndrey P Anokhin - Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USADanielle M Dick - Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, USAHoward J Edenberg - Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USAJohn R Kramer - Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA, USASamuel Kuperman - Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA, USAVivia V McCutcheon - Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USAJohn I Nurnberger Jr - Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USABernice Porjesz - Department of Psychiatry, SUNY Downstate Medical Center, Brooklyn, NY, USAMarc A Schuckit - Department of Psychiatry, University of California San Diego Medical School, San Diego, CA, USAJay Tischfield - Department of Genetics, Rutgers, The State University of New Jersey, Piscataway, NJ, USAKathleen K Bucholz - Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USAArpana Agrawal - Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USA
- Resource Type
- Journal article
- Publication Details
- Addiction (Abingdon, England), Vol.114(4), pp.687-697
- Publisher
- England
- DOI
- 10.1111/add.14512
- PMID
- 30474892
- PMCID
- PMC6411425
- ISSN
- 1360-0443
- eISSN
- 1360-0443
- Grant note
- K01 AA024152 / NIAAA NIH HHS R01 DA040716 / NIDA NIH HHS U01 MH109536 / NIMH NIH HHS K02 AA018755 / NIAAA NIH HHS U01 MH109532 / NIMH NIH HHS K01 DA037914 / NIDA NIH HHS U10 AA008401 / NIAAA NIH HHS K02 DA032573 / NIDA NIH HHS P30 CA086862 / NCI NIH HHS R01 DA040411 / NIDA NIH HHS
- Language
- English
- Date published
- 04/2019
- Academic Unit
- Psychiatry; Stead Family Department of Pediatrics
- Record Identifier
- 9984003479402771
Metrics
39 Record Views